SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-248227
Filing Date
2013-06-05
Accepted
2013-06-05 13:01:31
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d536565d10q.htm 10-Q 682589
2 EX-31.1 d536565dex311.htm EX-31.1 9231
3 EX-31.2 d536565dex312.htm EX-31.2 9197
4 EX-32.1 d536565dex321.htm EX-32.1 3994
5 EX-32.2 d536565dex322.htm EX-32.2 3960
  Complete submission text file 0001193125-13-248227.txt   3341754

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT insy-20130331.xml EX-101.INS 315411
7 XBRL TAXONOMY EXTENSION SCHEMA insy-20130331.xsd EX-101.SCH 31831
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insy-20130331_cal.xml EX-101.CAL 43161
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insy-20130331_def.xml EX-101.DEF 201273
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE insy-20130331_lab.xml EX-101.LAB 275405
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insy-20130331_pre.xml EX-101.PRE 240045
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 13893654
SIC: 2834 Pharmaceutical Preparations